Expression of RPL36 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL36 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1306.3

Median expressionⁱ : 1030.22

Median follow up timeⁱ : 0.98

P scoreⁱ 0.063

3-year survival highⁱ 14%

3-year survival lowⁱ 8%

TCGA RNA samplesⁱ

Average TPM

1131.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2928.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2735.3
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2570.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2261.7
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	2177.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2162.1
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2116.1
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1906.7
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	1895.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1891.8
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1881.9
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1841.4
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1794.8
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1710.4
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1700.7
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	1690.8
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1657.4
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1629.5
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1596.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1580.8
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1569.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1541.7
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	1494.9
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1473.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1435.8
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1429.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1428.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1418.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1410.6
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1405.4
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1403.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1394.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1384.1
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1369.5
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1315.4
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1315.1
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1312.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1300.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1298.2
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1289.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1265.0
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1261.5
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1251.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1249.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1249.2
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1241.9
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1226.0
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1219.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1208.9
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1188.3
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1184.5
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1181.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1158.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1142.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1136.1
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1127.4
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1116.7
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1115.3
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1093.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1087.4
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1086.2
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1083.7
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1080.7
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1075.6
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1071.8
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1067.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1057.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1040.5
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1038.4
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1033.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1030.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1019.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1014.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1009.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1004.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	994.0
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	992.0
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	980.1
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	963.6
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	961.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	960.7
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	960.4
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	952.6
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	952.2
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	946.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	946.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	946.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	944.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	937.4
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	936.5
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	936.3
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	931.1
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	929.7
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	918.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	905.4
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	893.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	890.2
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	884.0
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	883.1
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	878.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	870.1
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	860.6
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	855.8
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	853.9
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	840.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	836.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	836.4
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	826.4
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	812.7
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	810.9
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	794.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	771.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	766.1
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	759.6
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	759.4
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	755.9
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	750.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	732.2
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	728.0
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	720.7
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	708.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	698.4
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	695.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	689.6
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	685.5
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	684.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	680.7
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	670.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	661.4
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	659.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	652.9
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	649.0
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	643.2
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	616.1
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	611.9
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	575.4
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	567.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	524.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	509.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	411.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	392.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL36 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 16.47

Median expressionⁱ : 30.3

Median follow up timeⁱ : 0.99

P scoreⁱ 0.31

3-year survival highⁱ 23%

3-year survival lowⁱ 42%

TCGA RNA samplesⁱ

Average TPM

32.1

Number of samples

Samples

Sample	Description	TPM
AK074	N, NA, stage:NA, alive, 300 days	81.5
AK098	N, NA, stage:NA, dead, 660 days	78.0
AK139	N, NA, stage:NA, dead, 270 days	73.4
AK178	N, NA, stage:NA, dead, 240 days	71.5
AK053	N, NA, stage:NA, dead, 300 days	56.0
AK055	N, NA, stage:NA, dead, 240 days	51.4
AK183	N, NA, stage:NA, alive, 360 days	51.2
AK188	N, NA, stage:NA, alive, 420 days	51.0
AK142	N, NA, stage:NA, alive, 90 days	49.4
AK043	N, NA, stage:NA, alive, 660 days	48.1
AK165	N, NA, stage:NA, alive, 360 days	46.5
AK236	N, NA, stage:NA, dead, 360 days	46.1
AK133	N, NA, stage:NA, dead, 360 days	43.4
AK072	N, NA, stage:NA, dead, 150 days	42.6
AK153	N, NA, stage:NA, dead, 240 days	41.2
AK049	N, NA, stage:NA, dead, 180 days	40.8
AK088	N, NA, stage:NA, dead, 360 days	39.4
AK195	N, NA, stage:NA, dead, 390 days	36.7
AK089	N, NA, stage:NA, dead, 330 days	36.2
AK185	N, NA, stage:NA, alive, 330 days	35.9
AK051	N, NA, stage:NA, dead, 360 days	34.6
AK213	N, NA, stage:NA, alive, 2010 days	34.1
AK002	N, NA, stage:NA, dead, 570 days	32.9
AK158	N, NA, stage:NA, dead, 360 days	32.3
AK124	N, NA, stage:NA, alive, 1920 days	31.8
AK167	N, NA, stage:NA, dead, 180 days	31.6
AK071	N, NA, stage:NA, dead, 540 days	31.2
AK068	N, NA, stage:NA, alive, 360 days	31.2
AK199	N, NA, stage:NA, alive, 1860 days	30.7
AK035	N, NA, stage:NA, dead, 210 days	29.9
AK100	N, NA, stage:NA, alive, 960 days	29.5
AK123	N, NA, stage:NA, dead, 180 days	27.6
AK134	N, NA, stage:NA, dead, 360 days	26.9
AK216	N, NA, stage:NA, dead, 360 days	26.7
AK117	N, NA, stage:NA, dead, 210 days	26.5
AK091	N, NA, stage:NA, dead, 210 days	26.0
AK066	N, NA, stage:NA, alive, 960 days	26.0
AK149	N, NA, stage:NA, dead, 420 days	22.9
AK231	N, NA, stage:NA, dead, 240 days	21.6
AK015	N, NA, stage:NA, alive, 720 days	21.0
AK205	N, NA, stage:NA, dead, 120 days	20.7
AK227	N, NA, stage:NA, alive, 300 days	20.5
AK173	N, NA, stage:NA, dead, 180 days	20.2
AK218	N, NA, stage:NA, dead, 180 days	19.8
AK099	N, NA, stage:NA, dead, 420 days	18.2
AK079	N, NA, stage:NA, dead, 210 days	17.0
AK030	N, NA, stage:NA, dead, 120 days	15.9
AK076	N, NA, stage:NA, alive, 660 days	15.5
AK226	N, NA, stage:NA, dead, 360 days	14.4
AK102	N, NA, stage:NA, alive, 1740 days	13.9
AK041	N, NA, stage:NA, alive, 810 days	13.4
AK005	N, NA, stage:NA, dead, 240 days	13.2
AK003	N, NA, stage:NA, dead, 600 days	13.1
AK103	N, NA, stage:NA, alive, 1320 days	11.8
AK156	N, NA, stage:NA, dead, 330 days	11.5
AK081	N, NA, stage:NA, dead, 180 days	11.2
AK006	N, NA, stage:NA, dead, 360 days	10.6
AK085	N, NA, stage:NA, alive, 660 days	8.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218330004	Tumor	0.9
CPT0168830003	Tumor	0.6
CPT0182580003	Tumor	0.6
CPT0093510003	Tumor	0.6
CPT0125510003	Tumor	0.5
CPT0225760003	Tumor	0.5
CPT0218830004	Tumor	0.4
CPT0217060003	Tumor	0.4
CPT0228220003	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0161730003	Tumor	0.4
CPT0089150003	Tumor	0.4
CPT0207090003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0079790003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0221180003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0224540004	Tumor	0.3
CPT0216920008	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0087570003	Tumor	0.2
CPT0206560003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0189570004	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0201710003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0205450004	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0189650004	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0217880003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0207030003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0125220003	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0205570003	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0217100003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0206880003	Tumor	-0.1
CPT0087950003	Tumor	-0.1
CPT0125570003	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0204380003	Normal	-0.1
CPT0167640003	Tumor	-0.1
CPT0162020003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0162140003	Tumor	-0.2
CPT0093450003	Tumor	-0.2
CPT0204390003	Normal	-0.2
CPT0071100003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0127480003	Tumor	-0.2
CPT0205780003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0217000004	Tumor	-0.2
CPT0123530003	Tumor	-0.2
CPT0002410011	Tumor	-0.2
CPT0104330003	Tumor	-0.3
CPT0204360003	Normal	-0.3
CPT0078580003	Tumor	-0.3
CPT0104220003	Tumor	-0.3
CPT0206110003	Tumor	-0.3
CPT0190240004	Tumor	-0.3
CPT0218890004	Tumor	-0.3
CPT0171580008	Tumor	-0.4
CPT0182550003	Tumor	-0.4
CPT0218770003	Tumor	-0.4
CPT0204410003	Normal	-0.4
CPT0199770003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0204350003	Normal	-0.5
CPT0162100003	Tumor	-0.5
CPT0206330003	Tumor	-0.6
CPT0189250003	Tumor	-0.6
CPT0204370003	Normal	-0.6
CPT0206230003	Tumor	-0.7
CPT0204330003	Normal	-0.8
CPT0204400003	Normal	-0.8
CPT0204420003	Normal	-1.3
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA047153
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade